💠💠Drug firm Aurobindo Pharma on Wednesday reported a 39.52% rise in consolidated net profit to ₹635.68 crore for the quarter ended June 2019, mainly on account of robust sales in the US and Europe.
The company had posted a net profit of ₹455.59 crore for the corresponding period of the previous fiscal, Aurobindo Pharma said in a BSE filing.
Consolidated total revenue from operations rose to ₹5,444.60 crore for the quarter under consideration as against ₹4,250.27 crore for the same period a year ago, it added.
NEWS AND PIC CREDIT - MINT
Regards,
AMIT KONAR
Proprietor
KONAR TRADE TALK ™